Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gernot Marx

Showing results (251-260 of 291) with videos related to

Pageof 30
Sort By:
Trials|June 3, 2021
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsisGernot Marx, Kai Zacharowski, Carole Ichai, et al.
Journal of Clinical Medicine|September 16, 2020
The <i>Macrophage Migration Inhibitory Factor</i> (<i>MIF</i>) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac SurgeryLuisa Averdunk, Jürgen Bernhagen, Karl Fehnle, et al.
Respiratory Research|February 22, 2023
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trialHelene A Haeberle, Stefanie Calov, Peter Martus, et al.
Frontiers in Medicine|July 10, 2023
Recommendations on the structure, personal, and organization of intensive care unitsChristian Waydhas, Reimer Riessen, Andreas Markewitz, et al.
JCI Insight|March 28, 2020
Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsisElisabeth Zechendorf, Caroline E O'Riordan, Lara Stiehler, et al.
Trials|March 6, 2019
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trialChristina Kalvelage, Kai Zacharowski, Artur Bauhofer, et al.
European Journal of Anaesthesiology|April 5, 2016
Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in GermanyGernot Marx, Achim W Schindler, Christoph Mosch, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 26, 2023
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)Kerstin Rahn, Ali T Abdallah, Lin Gan, et al.
Critical Care Explorations|November 22, 2021
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock-A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, Andreas Weyland, Gernot Marx, et al.
Scientific Reports|January 15, 2022
Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatmentDaniek A M Meijs, Bas C T van Bussel, Björn Stessel, et al.
Pageof 30

Showing results (251-260 of 291) with videos related to

Sort By:
Pageof 30
Trials|June 3, 2021
Efficacy and safety of early target-controlled plasma volume replacement with a balanced gelatine solution versus a balanced electrolyte solution in patients with severe sepsis/septic shock: study protocol, design, and rationale of a prospective, randomized, controlled, double-blind, multicentric, international clinical trial : GENIUS-Gelatine use in ICU and sepsisGernot Marx, Kai Zacharowski, Carole Ichai, et al.
Journal of Clinical Medicine|September 16, 2020
The <i>Macrophage Migration Inhibitory Factor</i> (<i>MIF</i>) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac SurgeryLuisa Averdunk, Jürgen Bernhagen, Karl Fehnle, et al.
Respiratory Research|February 22, 2023
Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trialHelene A Haeberle, Stefanie Calov, Peter Martus, et al.
Frontiers in Medicine|July 10, 2023
Recommendations on the structure, personal, and organization of intensive care unitsChristian Waydhas, Reimer Riessen, Andreas Markewitz, et al.
JCI Insight|March 28, 2020
Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsisElisabeth Zechendorf, Caroline E O'Riordan, Lara Stiehler, et al.
Trials|March 6, 2019
Personalized medicine with IgGAM compared with standard of care for treatment of peritonitis after infectious source control (the PEPPER trial): study protocol for a randomized controlled trialChristina Kalvelage, Kai Zacharowski, Artur Bauhofer, et al.
European Journal of Anaesthesiology|April 5, 2016
Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in GermanyGernot Marx, Achim W Schindler, Christoph Mosch, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|November 26, 2023
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1)Kerstin Rahn, Ali T Abdallah, Lin Gan, et al.
Critical Care Explorations|November 22, 2021
Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock-A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)Michael Bauer, Andreas Weyland, Gernot Marx, et al.
Scientific Reports|January 15, 2022
Better COVID-19 Intensive Care Unit survival in females, independent of age, disease severity, comorbidities, and treatmentDaniek A M Meijs, Bas C T van Bussel, Björn Stessel, et al.
Pageof 30